© 2005 Oxford University Press
ARTICLE |
Family History of Hematopoietic Malignancy and Risk of Lymphoma
Affiliations of authors: Department of Medical Epidemiology and Biostatistics (ETC, KES, H-OA) and Department of Oncology and Pathology (AP-M, BG), Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology Research, Danish Epidemiology Science Center, Statens Serum Institut, Copenhagen, Denmark (HH); Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden (GR); Department of Oncology, Radiology and Clinical Immunology, University of Uppsala, Uppsala, Sweden (BG)
Correspondence to: Ellen T. Chang, ScD, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, SE-171 77, Stockholm, Sweden (e-mail: ellen.chang{at}meb.ki.se).
Background: A family history of hematopoietic malignancy is associated with an increased risk of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL), although the magnitude of the relative risk is unclear. We estimated the association between familial hematopoietic cancer and risk of lymphoma using validated, registry-based family data, and we also investigated whether associations between some environmental exposures and risk of lymphoma vary between individuals with and without such a family history. Methods: In a population-based casecontrol study of malignant lymphoma, 1506 case patients and 1229 control subjects were linked to the Swedish Multi-Generation Register and then to the Swedish Cancer Register to ascertain history of cancer in first-degree relatives of patients with malignant lymphoma. Multiple logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations with the risk of lymphoma. Results: A history of hematopoietic malignancy in any first-degree relative was associated with an increased risk of all NHL (OR = 1.8, 95% CI = 1.2 to 2.5), common B-cell NHL subtypes, and HL. Relative risks were generally stronger in association with sibling hematopoietic cancer (OR for all NHL = 3.2, 95% CI = 1.3 to 7.6) than with parental hematopoietic cancer (OR = 1.6, 95% CI = 1.1 to 2.3). A family history of NHL or chronic lymphocytic leukemia (CLL) was associated with an increased risk of several NHL subtypes and HL, whereas familial multiple myeloma was associated with a higher risk of follicular lymphoma. There was no statistically significant heterogeneity in NHL risk associations with environmental factors between individuals with and without familial hematopoietic malignancy. Conclusions: The increased risk of NHL and HL among individuals with a family history of hematopoietic malignancy was approximately twofold for both lymphoma types. There was no evidence that etiologic associations varied between familial NHL and nonfamilial NHL.
This article has been cited by other articles:
![]() |
B. C.-H. Chiu, Q. Lan, B. J. Dave, A. Blair, S. H. Zahm, and D. D. Weisenburger The Utility of t(14;18) in Understanding Risk Factors for Non-Hodgkin Lymphoma J Natl Cancer Inst Monographs, July 1, 2008; 2008(39): 69 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Czene, H.-O. Adami, and E. T. Chang Sex- and Kindred-Specific Familial Risk of Non Hodgkin's Lymphoma Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2496 - 2499. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hjalgrim, K. Ekstrom-Smedby, K. Rostgaard, R.-M. Amini, D. Molin, S. Hamilton-Dutoit, C. Schollkopf, E. T. Chang, E. Ralfkiaer, H.-O. Adami, et al. Cigarette Smoking and Risk of Hodgkin Lymphoma: A Population-Based Case-Control Study Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1561 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Holick Vitamin D Deficiency N. Engl. J. Med., July 19, 2007; 357(3): 266 - 281. [Full Text] [PDF] |
||||
![]() |
C. F. Skibola, J. D. Curry, and A. Nieters Genetic susceptibility to lymphoma Haematologica, July 1, 2007; 92(7): 960 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Wang, S. L. Slager, P. Brennan, E. A. Holly, S. De Sanjose, L. Bernstein, P. Boffetta, J. R. Cerhan, M. Maynadie, J. J. Spinelli, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph) Blood, April 15, 2007; 109(8): 3479 - 3488. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C.-H. Chiu, B. J. Dave, A. Blair, S. M. Gapstur, J. S. Chmiel, A. J. Fought, S. H. Zahm, and D. D. Weisenburger Cigarette Smoking, Familial Hematopoietic Cancer, Hair Dye Use, and Risk of t(14;18)-defined Subtypes of Non-Hodgkin's Lymphoma Am. J. Epidemiol., March 15, 2007; 165(6): 652 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Wang, J. R. Cerhan, P. Hartge, S. Davis, W. Cozen, R. K. Severson, N. Chatterjee, M. Yeager, S. J. Chanock, and N. Rothman Common Genetic Variants in Proinflammatory and Other Immunoregulatory Genes and Risk for Non-Hodgkin Lymphoma Cancer Res., October 1, 2006; 66(19): 9771 - 9780. [Abstract] [Full Text] [PDF] |
||||
![]() |
J H Mandel, M A Kelsh, P J Mink, D D Alexander, R M Kalmes, M Weingart, L Yost, and M Goodman Occupational trichloroethylene exposure and non-Hodgkin's lymphoma: a meta-analysis and review Occup. Environ. Med., September 1, 2006; 63(9): 597 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Bracci, T. B. Dalvi, and E. A. Holly Residential history, family characteristics and non-hodgkin lymphoma, a population-based case-control study in the san francisco bay area. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1287 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Negri, R. Talamini, M. Montella, L. Dal Maso, A. Crispo, M. Spina, C. La Vecchia, and S. Franceschi Family History of Hemolymphopoietic and Other Cancers and Risk of Non-Hodgkin's Lymphoma. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 245 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Chang, K. E. Smedby, H. Hjalgrim, B. Glimelius, and H.-O. Adami Reliability of Self-Reported Family History of Cancer in a Large Case-Control Study of Lymphoma J Natl Cancer Inst, January 4, 2006; 98(1): 61 - 68. [Abstract] [Full Text] [PDF] |
||||








